{"id":"aspirin-celecoxib","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal bleeding or ulceration"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Cardiovascular events"},{"rate":null,"effect":"Renal impairment"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin irreversibly inhibits both COX-1 and COX-2 enzymes, while celecoxib selectively inhibits COX-2. Together they provide complementary anti-inflammatory, analgesic, and antipyretic effects by suppressing prostaglandin production. This combination approach may enhance therapeutic efficacy, though it carries increased gastrointestinal and cardiovascular risk compared to monotherapy.","oneSentence":"This combination inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation through dual NSAID action.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:41:00.709Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Osteoarthritis"},{"name":"Acute pain conditions"}]},"trialDetails":[{"nctId":"NCT03590821","phase":"EARLY_PHASE1","title":"Timed Aspirin Chronobiome Study","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2027-12","conditions":"Healthy","enrollment":60},{"nctId":"NCT06076837","phase":"PHASE1","title":"The Seven Trial: Exploiting the Unfolded Protein Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2025-01-09","conditions":"Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic","enrollment":6},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT04147013","phase":"PHASE4","title":"Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-02-18","conditions":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","enrollment":44},{"nctId":"NCT03728179","phase":"PHASE1","title":"RACIN in Patients With Advanced TIL-negative Solid Tumors","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2019-01-16","conditions":"Solid Tumor, Adult","enrollment":40},{"nctId":"NCT05994287","phase":"NA","title":"Pain Treatment With Combinations of NSAIDs","status":"COMPLETED","sponsor":"Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty","startDate":"2021-01-01","conditions":"Postoperative Pain, Acute","enrollment":105},{"nctId":"NCT03638297","phase":"PHASE2","title":"PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2018-08-23","conditions":"Colorectal Cancer","enrollment":29},{"nctId":"NCT00137033","phase":"PHASE4","title":"Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-09","conditions":"Peptic Ulcers","enrollment":605},{"nctId":"NCT04757792","phase":"","title":"Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-06-06","conditions":"COVID-19 Disease","enrollment":475},{"nctId":"NCT03699293","phase":"PHASE4","title":"NSAIDs vs. Coxibs in the Presence of Aspirin","status":"RECRUITING","sponsor":"Inova Health Care Services","startDate":"2018-09-22","conditions":"Rheumatoid Arthritis, Cardiovascular Diseases","enrollment":30},{"nctId":"NCT00152724","phase":"","title":"Mechanisms of Human Cutaneous Microcirculation in Healthy Volunteers","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"1996-01","conditions":"Healthy Volunteers","enrollment":85},{"nctId":"NCT01796951","phase":"EARLY_PHASE1","title":"Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2013-02","conditions":"Tobacco Use Disorder, Smoking","enrollment":6},{"nctId":"NCT01638962","phase":"NA","title":"The Effect on Knee Joint Loads of Analgesic Use Compared With Exercise in Patients With Knee Osteoarthritis - An RCT","status":"COMPLETED","sponsor":"University of Southern Denmark","startDate":"2012-08","conditions":"Osteoarthritis, Knee","enrollment":93},{"nctId":"NCT00882388","phase":"PHASE4","title":"The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2005-03","conditions":"Healthy","enrollment":40},{"nctId":"NCT00261586","phase":"PHASE4","title":"A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"","conditions":"Analgesics","enrollment":92},{"nctId":"NCT00175032","phase":"PHASE3","title":"A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin","status":"COMPLETED","sponsor":"Takeda","startDate":"2003-07","conditions":"Osteoarthritis, Peptic Ulcer","enrollment":1045},{"nctId":"NCT00700687","phase":"PHASE1","title":"Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib","status":"COMPLETED","sponsor":"POZEN","startDate":"2008-06","conditions":"Healthy","enrollment":90},{"nctId":"NCT00778193","phase":"PHASE4","title":"Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers","status":"COMPLETED","sponsor":"Research Associates of New York, LLP","startDate":"2007-10","conditions":"Gastroduodenal Ulcer","enrollment":125},{"nctId":"NCT00565500","phase":"PHASE4","title":"Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin","status":"COMPLETED","sponsor":"University of Chieti","startDate":"2003-04","conditions":"Ischemic Heart Disease, Osteoarthritis","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["aspirin : Keun-Hwa Phamaceutical","clopidogrel : sanofi-aventis","celecoxib : Pfizer"],"phase":"marketed","status":"active","brandName":"aspirin + celecoxib","genericName":"aspirin + celecoxib","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation through dual NSAID action. Used for Rheumatoid arthritis, Osteoarthritis, Acute pain conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}